A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION

被引：0
|
作者：
Kirschbaum, M. H. [1 ]
Stein, A. S. [1 ]
Nakamura, R. [1 ]
Auayporn, N. [1 ]
Popplewell, L. [1 ]
Delioukina, M. [1 ]
Chen, R. [1 ]
Snyder, D. [1 ]
Conrad, J. [1 ]
Frankel, P. [1 ]
Forman, S. J. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
323
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [41] A Phase I-II Dose Escalation Trial of Clofarabine plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia
    Boulad, Farid
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Small, Trudy N.
    Klein, Elizabeth G.
    Barker, Juliet
    Jakubowski, Ann A.
    Koehne, Guenther
    Papadopoulos, Esperanza
    Perales, Miguel-Angel
    Young, James W.
    O'Reilly, Richard J.
    BLOOD, 2010, 116 (21) : 973 - 973
  • [42] Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?
    Hsu, Jingmei
    Van Besien, Koen
    Baron, Frederic
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1529 - 1534
  • [43] A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
    Biran, Noa
    Rowley, Scott D.
    Vesole, David H.
    Zhang, Shijia
    Donato, Michele L.
    Richter, Joshua
    Skarbnik, Alan P.
    Pecora, Andrew
    Siegel, David S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2165 - 2171
  • [44] Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia
    S S Farag
    L L Wood
    J E Schwartz
    S Srivastava
    R P Nelson
    M J Robertson
    R Abonour
    A Secrest
    E Cox
    J Baute
    C Sullivan
    K Kane
    D R Jones
    Leukemia, 2011, 25 : 599 - 605
  • [45] Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia
    Farag, S. S.
    Wood, L. L.
    Schwartz, J. E.
    Srivastava, S.
    Nelson, R. P., Jr.
    Robertson, M. J.
    Abonour, R.
    Secrest, A.
    Cox, E.
    Baute, J.
    Sullivan, C.
    Kane, K.
    Jones, D. R.
    LEUKEMIA, 2011, 25 (04) : 599 - 605
  • [46] High-dose idarubicin (I) and melphalan (M) with total body irradiation (TBI) or busulfan (Bu) as conditioning for allogeneic and autologous transplantation (SCT).
    Juliusson, G
    Malm, C
    Karlsson, K
    BONE MARROW TRANSPLANTATION, 1999, 23 : S74 - S74
  • [47] A Phase I Dose Escalation Study of Lenalidomide Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
    Andritsos, Leslie A.
    Blum, William
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Penza, Sam
    Lee, Jodi
    Marcucci, Guido
    Byrd, John C.
    Devine, Steven M.
    BLOOD, 2014, 124 (21)
  • [48] High dose topotecan plus melphalan: A safe and tolerable preparative regimen for autologous transplantation in multiple myeloma.
    Holman, PR
    Bashey, A
    Corringham, SM
    Carrier, E
    O'Quigley, J
    Ball, E
    BLOOD, 1999, 94 (10) : 578A - 578A
  • [49] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    Bregni, M
    De Fabritiis, P
    Musso, M
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S70 - S70
  • [50] A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia
    Yabe, Miharu
    Sako, Masahiro
    Yabe, Hiromasa
    Osugi, Yuko
    Kurosawa, Hidemitsu
    Nara, Taemi
    Tokuyama, Mika
    Adachi, Souichi
    Kobayashi, Chie
    Yanagimachi, Masakatsu
    Ohtsuka, Yoshitoshi
    Nakazawa, Yozo
    Ogawa, Chitose
    Manabe, Atsushi
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 862 - 867
12345